taPentadol cLinical prAcTice IN belgiUM
NCT03814993 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2022-02-09
Summary
Multicenter observational study to determine the long-term tolerability and analgesic effectiveness of oral tapentadol in patients suffering from severe pain syndromes, refractory to other strong opioids.
Conditions
- Severe Pain Syndromes
Sponsors & Collaborators
-
Grünenthal GmbH
collaborator INDUSTRY -
Dafne Balemans
lead OTHER
Principal Investigators
-
Guy Hans, Prof. · University Hospital, Antwerp
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-29
- Primary Completion
- 2021-08-01
- Completion
- 2021-08-01
Countries
- Belgium
Study Locations
More Related Trials
-
A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain
NCT02151682 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of the Antihyperalgesic Effect of Tapentadol in Two Human Experimental Models
NCT01615510 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability
NCT00986258 ·Status: TERMINATED ·Phase: PHASE3
-
Pharmacokinetic Characterization of Two Novel CG5503 Tablet Formulations in Healthy Volunteers
NCT03956134 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Look at Tapentadol Oral Solution in Children and Adolescents in Pain
NCT02081391 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking Either WHO Step I or Step II Analgesics or no Regular Analgesic
NCT00983073 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain
NCT00487435 ·Status: COMPLETED ·Phase: PHASE3
-
Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis
NCT00771758 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic Pain
NCT00364546 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain
NCT00361504 ·Status: COMPLETED ·Phase: PHASE3
-
Tapentadol in Chronic Malignant Tumour Related Pain
NCT01264887 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine
NCT00472303 ·Status: COMPLETED ·Phase: PHASE3
-
A Non-interventional, Observational Study for Targinact® Treatment in Patients With Chronic Severe Pain
NCT01710904 ·Status: COMPLETED
-
Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain
NCT01081912 ·Status: COMPLETED ·Phase: PHASE3
-
Tapentadol (CG5503)
NCT00421928 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 1 Pharmacokinetic Study of Tapentadol Prolonged-Release 250 Milligram (mg) Formulation in Healthy Participants
NCT01877226 ·Status: COMPLETED ·Phase: PHASE1
-
Long-Term Safety and Tolerability Study of NKTR-181 in Subjects With Chronic Low Back Pain or Chronic Non-Cancer Pain
NCT02367820 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
NCT00763321 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
NCT00486811 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Safety and Effectiveness of Switching Between Two Forms of Tapentadol in Patients With Chronic Low Back Pain
NCT00594516 ·Status: COMPLETED ·Phase: PHASE3
-
NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain
NCT00986180 ·Status: COMPLETED ·Phase: PHASE3
-
Preemptive Tapentadol on Post-operative Analgesia Following Total Knee Arthroplasty
NCT03351517 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain
NCT01729728 ·Status: COMPLETED ·Phase: PHASE2
-
Opioid Taper Study
NCT03912298 ·Status: COMPLETED
-
An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)
NCT01631513 ·Status: WITHDRAWN ·Phase: PHASE4